Skip to main content
Fig. 3 | Gut Pathogens

Fig. 3

From: The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn’s disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trial

Fig. 3

Visualisation of the gut microbiome at week 8 divided into two groups: participants with a reduction in BWT (red) and participants with no reduction (blue/green). There were no differences in beta diversity between the groups after eight weeks of treatment (Bif195/placebo), and no species were differentially abundant

Back to article page

Gut Pathogens

ISSN: 1757-4749